Candesartan cilexetil in cardiovascular prevention
Effectiveness and good tolerability of angiotensin receptor antagonists (ARA) in arterial hypertension (AH) have been demonstrated in large-scale randomized clinical trials. Substantial pharmacodynamic differences between various ARA, potentially playing important clinical roles, were identified. Ca...
Saved in:
| Main Author: | A. Ya. Ivleva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization and validation of UPLC method for dapagliflozin and candesartan cilexetil in an on-demand formulation: Analytical quality by design approach
by: Elzayat Ehab M., et al.
Published: (2025-07-01) -
Technological approaches to improve the bioavailability of the poor soluble substance Candesartan Cilexetil in mini-tablets
by: K. M. Tserkovnaya, et al.
Published: (2025-03-01) -
Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension
by: N. M. Chikhladze, et al.
Published: (2008-12-01) -
Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter
by: Ya. V. Zemlyaniy
Published: (2014-04-01) -
Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01)